Premier's Profit Plunges 75% Amid Revenue Dip, Higher Interest Costs

TL;DR

**Premier's Q1 results are a red flag, with profits cratering 75% – I'm bearish on PINC until the Patient Square deal clarifies the path forward.**

AI Summary

Premier, Inc. reported a significant decline in net income attributable to stockholders, falling to $17.579 million for the three months ended September 30, 2025, a substantial decrease from $70.784 million in the prior-year period. This 75.1% drop was primarily driven by a sharp reduction in 'Other income, net,' which plummeted from $60.259 million in Q1 2024 to $1.080 million in Q1 2025, and a substantial increase in interest expense, net, from $1.756 million to $5.622 million. Total net revenue also saw a slight decrease, from $248.142 million in Q1 2024 to $240.004 million in Q1 2025, a 3.3% reduction. Operating income decreased by 29.5%, from $35.315 million to $24.884 million. The company's cash and cash equivalents decreased by 48.2% from $83.725 million at June 30, 2025, to $43.380 million at September 30, 2025. A proposed merger with an affiliate of Patient Square Capital introduces significant risks, including potential delays in regulatory approvals and difficulties in retaining key personnel. The company also faces ongoing competitive pressures in its GPO business and challenges in converting licensed-based customers to SaaS subscriptions.

Why It Matters

This significant profit decline for Premier, Inc. signals potential headwinds for investors, particularly given the ongoing proposed acquisition by Patient Square Capital. The substantial drop in 'Other income, net' and increased interest expense suggest a less favorable financial environment, which could impact the deal's valuation or even its completion. For employees and customers, a financially weaker Premier might lead to reduced investment in new services or operational efficiencies, potentially affecting service quality or job security. In the broader market, this performance highlights the competitive pressures in the healthcare group purchasing organization (GPO) and software sectors, where Premier competes with other major players, and the impact of rising interest rates on corporate profitability.

Risk Assessment

Risk Level: high — The risk level is high due to the 75.1% decrease in net income attributable to stockholders, from $70.784 million in Q1 2024 to $17.579 million in Q1 2025, and a 48.2% reduction in cash and cash equivalents from $83.725 million to $43.380 million. Additionally, the filing explicitly lists numerous risks related to the proposed merger with Patient Square Capital, including the inability to consummate the merger, disruption from the merger, and significant transaction costs, indicating substantial uncertainty.

Analyst Insight

Investors should exercise extreme caution and consider reducing exposure to Premier, Inc. given the sharp decline in profitability and cash reserves. Monitor closely for updates on the proposed acquisition by Patient Square Capital, as its success or failure will be a critical determinant of future valuation. Evaluate the impact of increased interest expenses and the significant drop in 'Other income, net' on the company's long-term financial health.

Financial Highlights

revenue

$240,004,000

total Assets

$3,051,371,000

net Income

$17,579,000

eps

$0.21

cash Position

$43,380,000

revenue Growth

-3.3%

Revenue Breakdown

Key Numbers

• $17.579M — Net income attributable to stockholders (Decreased 75.1% from $70.784 million in Q1 2024)
• $240.004M — Total net revenue (Decreased 3.3% from $248.142 million in Q1 2024)
• $43.380M — Cash and cash equivalents (Decreased 48.2% from $83.725 million at June 30, 2025)
• $1.080M — Other income, net (Significantly decreased from $60.259 million in Q1 2024)
• $5.622M — Interest expense, net (Increased from $1.756 million in Q1 2024)
• $24.884M — Operating income (Decreased 29.5% from $35.315 million in Q1 2024)
• $0.21 — Diluted earnings per share attributable to stockholders (Decreased from $0.70 in Q1 2024)
• 82,684,436 — Shares of Class A common stock outstanding (As of October 30, 2025)
• $18.561M — Cash dividends paid (For the three months ended September 30, 2025)
• $19.504M — Purchases of property and equipment (For the three months ended September 30, 2025)

Key Players & Entities

• Premier, Inc. (company) — registrant and holding company
• Patient Square Capital (company) — affiliate proposing to acquire Premier, Inc.
• Premier Healthcare Solutions, Inc. (company) — wholly owned subsidiary of Premier, Inc.
• OMNIA Partners, LLC (company) — purchaser of non-healthcare GPO member contracts
• SEC (regulator) — Securities and Exchange Commission
• NASDAQ Global Select Market (regulator) — exchange where Class A Common Stock is registered
• Office of the National Coordinator for Health Information Technology (regulator) — issues ONC Rules for Health Information Technology products
• Food and Drug Administration (regulator) — regulates software applications considered medical devices
• Private Securities Litigation Reform Act of 1995 (regulator) — governs forward-looking statements
• Patient Protection and Affordable Care Act (regulator) — healthcare legislation affecting organizations

FAQ

Risk Factors

• Merger Uncertainty [high — financial]: The proposed merger with an affiliate of Patient Square Capital introduces significant risks. These include potential delays in obtaining necessary regulatory approvals, which could impact the transaction timeline and shareholder value. Additionally, there is a risk of difficulties in retaining key personnel during the transition period.
• Competitive Pressures [medium — market]: Premier, Inc. faces ongoing competitive pressures within its Group Purchasing Organization (GPO) business. This competitive landscape can impact market share and pricing power, potentially affecting revenue and profitability.
• SaaS Transition Challenges [medium — operational]: The company faces challenges in converting its existing licensed-based customers to Software as a Service (SaaS) subscriptions. This transition is crucial for future revenue models but may encounter resistance or technical hurdles.
• Declining Other Income [high — financial]: A substantial decrease in 'Other income, net' from $60.259 million in Q1 2024 to $1.080 million in Q1 2025 significantly impacted net income. This reduction represents a 98.2% drop and is a primary driver of the overall earnings decline.
• Increased Interest Expense [medium — financial]: Interest expense, net, increased from $1.756 million to $5.622 million for the three months ended September 30, 2025, compared to the prior year. This 220.1% increase adds to the company's cost of financing and reduces net income.
• Reduced Cash Position [medium — financial]: Cash and cash equivalents saw a significant decrease of 48.2%, falling from $83.725 million at June 30, 2025, to $43.380 million at September 30, 2025. This reduction in liquidity could impact operational flexibility and investment capacity.

Industry Context

Premier, Inc. operates within the healthcare supply chain and technology sector. The industry is characterized by intense competition among Group Purchasing Organizations (GPOs) and a growing shift towards technology-enabled solutions like Software as a Service (SaaS). Healthcare providers are increasingly seeking cost efficiencies and data-driven insights, putting pressure on traditional business models.

Regulatory Implications

The proposed merger with an affiliate of Patient Square Capital will likely be subject to regulatory review, potentially including antitrust considerations. Delays or conditions imposed by regulators could impact the transaction's completion and terms. Compliance with data privacy and healthcare regulations remains a constant operational requirement.

What Investors Should Do

1. Monitor merger progress and regulatory approvals.
2. Analyze the impact of declining 'Other income' and rising interest expenses.
3. Evaluate the company's strategy for SaaS transition.
4. Assess the company's liquidity and cash burn rate.

Key Dates

• 2025-09-30: End of Q1 Fiscal Year 2025 — Reported significant decline in net income and revenue, with a substantial drop in cash and cash equivalents.
• 2025-06-30: End of Fiscal Year 2025 — Reported cash and cash equivalents of $83,725,000 prior to the Q1 decline.

Glossary

Net income attributable to stockholders

The portion of a company's profit that is allocated to its common shareholders after all expenses, interest, taxes, and preferred stock dividends have been paid. (Key indicator of profitability for common shareholders, which saw a significant 75.1% decrease.)

Other income, net

Income generated from sources other than the company's primary business operations, such as interest income, dividend income, or gains from asset sales. (A major contributor to the decline in net income, falling from $60.259 million to $1.080 million.)

Interest expense, net

The cost incurred by a company for borrowed funds, net of any interest income earned. (Increased by 220.1% from $1.756 million to $5.622 million, negatively impacting profitability.)

Cash and cash equivalents

Highly liquid short-term investments that can be readily converted into cash, including currency on hand, bank deposits, and money market funds. (Decreased by 48.2% to $43.380 million, indicating a reduced liquidity position.)

Group Purchasing Organization (GPO)

An entity created to help healthcare providers gain economies of scale by leveraging the purchasing power of its members to negotiate discounts with suppliers. (Premier's core business segment, which is facing ongoing competitive pressures.)

Software as a Service (SaaS)

A software distribution model where a third-party provider hosts applications and makes them available to customers over the Internet. (The company is facing challenges in converting its customer base to this newer subscription model.)

Accumulated deficit

The cumulative net losses of a company since its inception that have not been offset by net profits. (The company has a significant accumulated deficit of $686,998,000 as of September 30, 2025.)

Year-Over-Year Comparison

Compared to the prior-year period, Premier, Inc. experienced a substantial 75.1% decline in net income attributable to stockholders, driven by a dramatic drop in 'Other income, net' and a significant increase in interest expense. Total net revenue also decreased by 3.3%, indicating a slight contraction in the top line. Operating income fell by 29.5%, reflecting increased costs or reduced efficiency. The company's cash position has been significantly impacted, with cash and cash equivalents down 48.2% quarter-over-quarter.

Key Financial Figures

• $0.01 — which registered Class A Common Stock, $0.01 Par Value PINC NASDAQ Global Select Mar

Filing Documents

• pinc-20250930.htm (10-Q) — 1421KB
• ex101-pincxfy26x0930.htm (EX-10.1) — 10KB
• ex102-pincxfy26x0930.htm (EX-10.2) — 122KB
• ex311-pincxfy26x0930.htm (EX-31.1) — 11KB
• ex312-pincxfy26x0930.htm (EX-31.2) — 11KB
• ex321-pincxfy26x0930.htm (EX-32.1) — 6KB
• ex322-pincxfy26x0930.htm (EX-32.2) — 6KB
• 0001577916-25-000019.txt ( ) — 7753KB
• pinc-20250930.xsd (EX-101.SCH) — 53KB
• pinc-20250930_cal.xml (EX-101.CAL) — 100KB
• pinc-20250930_def.xml (EX-101.DEF) — 319KB
• pinc-20250930_lab.xml (EX-101.LAB) — 643KB
• pinc-20250930_pre.xml (EX-101.PRE) — 494KB
• pinc-20250930_htm.xml (XML) — 946KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION 6 Item 1.

Financial Statements

Financial Statements 6 Condensed Consolidated Balance Sheets (Unaudited) 6 Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) 7 Condensed Consolidated Statements of Stockholders' Equity (Unaudited) 8 Condensed Consolidated Statements of Cash Flows (Unaudited) 9 Notes to Condensed Consolidated Financial Statements (Unaudited) 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 43 Item 4.

Controls and Procedures

Controls and Procedures 43

OTHER INFORMATION

PART II. OTHER INFORMATION 45 Item 1.

Legal Proceedings

Legal Proceedings 45 Item 1A.

Risk Factors

Risk Factors 45 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 48 Item 5. Other Information 48 Item 6. Exhibits 49

Signatures

Signatures 50 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS risks related to the proposed transaction pursuant to which we would be acquired by an affiliate of Patient Square Capital (the "Merger"), including without limitation the following: (1) the inability to consummate the Merger within the anticipated time period, or at all, due to any reason, including the failure to obtain required regulatory approvals, satisfy the other conditions to the consummation of the Merger (including the approval of our stockholders) or complete contemplated financi

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements PREMIER, INC. Condensed Consolidated Balance Sheets (Unaudited) (In thousands, except share data) September 30, 2025 June 30, 2025 Assets Cash and cash equivalents $ 43,380 $ 83,725 Accounts receivable (net of $ 5,767 and $ 6,339 allowance for credit losses, respectively) 87,460 99,092 Contract assets (net of $ 1,189 and $ 1,207 allowance for credit losses, respectively) 330,699 318,337 Prepaid expenses and other current assets 70,473 84,649 Total current assets 532,012 585,803 Property and equipment (net of $ 819,366 and $ 820,043 accumulated depreciation, respectively) 200,211 201,481 Intangible assets (net of $ 342,898 and $ 332,522 accumulated amortization, respectively) 237,694 250,770 Goodwill 899,071 897,894 Deferred income tax assets 758,170 762,859 Deferred compensation plan assets 31,198 35,069 Investments in unconsolidated affiliates 259,261 262,621 Operating lease right-of-use assets 41,807 5,072 Other assets 91,947 95,505 Total assets $ 3,051,371 $ 3,097,074 Liabilities and stockholders' equity Accounts payable $ 24,078 $ 19,619 Accrued expenses 51,844 59,151 Revenue share obligations 349,059 347,306 Accrued compensation and benefits 49,421 99,019 Deferred revenue 19,786 22,548 Line of credit and current portion of long-term debt 280,000 280,000 Current portion of liability related to the sale of future revenues 53,618 49,712 Other current liabilities 26,939 33,182 Current liabilities of discontinued operations 24 96 Total current liabilities 854,769 910,633 Liability related to the sale of future revenues, less current portion 576,373 590,727 Deferred compensation plan obligations 31,198 35,069 Operating lease liabilities, less current portion 42,451 2,007 Other liabilities 18,307 28,061 Total liabilities 1,523,098 1,566,497 Commitments and contingencies (Note 15) Stockholders' equity: Class A common stock, $ 0.01 par value, 500,000,000 shares authorized; 82,684,147 shares

View Full Filing

View this 10-Q filing on SEC EDGAR